Skip to content

Clinical benefits of additional resistance-type exercise during an endurance-type exercise intervention in coronary artery disease patients

Clinical benefits of additional resistance-type exercise during an endurance-type exercise intervention in coronary artery disease patients: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN81212339
Enrollment
60
Registered
2010-02-09
Start date
2008-02-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease Circulatory System Chronic ischaemic heart disease

Interventions

All subjects exercised under close supervision of experienced physiotherapists three days per week for a total duration of six weeks in the cardiac rehabilitation centre of the hospital. Exercise trai

Sponsors

Heart Centre Hasselt vzw (Belgium)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 60 coronary artery disease (CAD) patients (aged between 45 - 80 years, either sex) agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Complicated hospitalisation (renal failure, sepsis) 2. Delayed and/or complicated sternum healing 3. Hypertension (greater than 150 mmHg systolic blood pressure at rest and/or greater than 250 mmHg systolic blood pressure during exercise) 4. Presence of pulmonary and renal co-morbidity 5. Peripheral artery disease 6. Orthopaedic limitations 7. Subjects presenting myocardial ischaemia and/or severe ventricular arrhythmias during baseline exercise testing

Design outcomes

Primary

MeasureTime frame
1. Maximal exercise capacity 2. Sub-maximal exercise capacity 3. Muscle strength 4. Blood plasma lipid profile and glycaemic control 5. Habitual activity level These measurements were executed at entry of rehabilitation, and after 7 weeks of rehabilitation.

Secondary

MeasureTime frame
1. Blood endothelial progenitor cell 2. Cytokine content These measurements were executed at entry of rehabilitation, and after 7 weeks of rehabilitation.

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026